Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.15
+0.57 (6.64%)
Jan 21, 2025, 4:00 PM EST - Market closed
Theravance Biopharma Employees
Theravance Biopharma had 99 employees as of December 31, 2023. The number of employees decreased by 12 or -10.81% compared to the previous year.
Employees
99
Change (1Y)
-12
Growth (1Y)
-10.81%
Revenue / Employee
$638,303
Profits / Employee
-$499,000
Market Cap
449.94M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
TBPH News
- 5 weeks ago - Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference - PRNewsWire
- 2 months ago - Theravance Biopharma to Participate in an Upcoming Investor Conference - PRNewsWire
- 2 months ago - Theravance Biopharma, Inc. (TBPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value - PRNewsWire
- 3 months ago - Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024 - PRNewsWire
- 3 months ago - Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease - PRNewsWire
- 6 months ago - Theravance Biopharma, Inc. (TBPH) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update - PRNewsWire